272 related articles for article (PubMed ID: 32471980)
1. The interaction of interleukin-8 and PTEN inactivation promotes the malignant progression of head and neck squamous cell carcinoma via the STAT3 pathway.
Xu Q; Ma H; Chang H; Feng Z; Zhang C; Yang X
Cell Death Dis; 2020 May; 11(5):405. PubMed ID: 32471980
[TBL] [Abstract][Full Text] [Related]
2. IL-8 promotes HNSCC progression on CXCR1/2-meidated NOD1/RIP2 signaling pathway.
Chan LP; Wang LF; Chiang FY; Lee KW; Kuo PL; Liang CH
Oncotarget; 2016 Sep; 7(38):61820-61831. PubMed ID: 27557518
[TBL] [Abstract][Full Text] [Related]
3. IL-6 promotes head and neck tumor metastasis by inducing epithelial-mesenchymal transition via the JAK-STAT3-SNAIL signaling pathway.
Yadav A; Kumar B; Datta J; Teknos TN; Kumar P
Mol Cancer Res; 2011 Dec; 9(12):1658-67. PubMed ID: 21976712
[TBL] [Abstract][Full Text] [Related]
4. Targeting of EZH2 inhibits epithelial‑mesenchymal transition in head and neck squamous cell carcinoma via regulating the STAT3/VEGFR2 axis.
Zhao M; Hu X; Xu Y; Wu C; Chen J; Ren Y; Kong L; Sun S; Zhang L; Jin R; Zhou X
Int J Oncol; 2019 Nov; 55(5):1165-1175. PubMed ID: 31545422
[TBL] [Abstract][Full Text] [Related]
5. (-)-Epigallocatechin gallate induces Fas/CD95-mediated apoptosis through inhibiting constitutive and IL-6-induced JAK/STAT3 signaling in head and neck squamous cell carcinoma cells.
Lin HY; Hou SC; Chen SC; Kao MC; Yu CC; Funayama S; Ho CT; Way TD
J Agric Food Chem; 2012 Mar; 60(10):2480-9. PubMed ID: 22313388
[TBL] [Abstract][Full Text] [Related]
6. The crosstalk between AXL and YAP promotes tumor progression through STAT3 activation in head and neck squamous cell carcinoma.
Li J; Shi C; Zhou R; Han Y; Xu S; Ma H; Zhang Z
Cancer Sci; 2020 Sep; 111(9):3222-3235. PubMed ID: 32589311
[TBL] [Abstract][Full Text] [Related]
7. Slug is a novel molecular target for head and neck squamous cell carcinoma stem-like cells.
Moon JH; Lee SH; Koo BS; Kim JM; Huang S; Cho JH; Eun YG; Shin HA; Lim YC
Oral Oncol; 2020 Dec; 111():104948. PubMed ID: 32771963
[TBL] [Abstract][Full Text] [Related]
8. High expression of ACTL8 is poor prognosis and accelerates cell progression in head and neck squamous cell carcinoma.
Li B; Zhu J; Meng L
Mol Med Rep; 2019 Feb; 19(2):877-884. PubMed ID: 30535476
[TBL] [Abstract][Full Text] [Related]
9. p53-targeted lincRNA-p21 acts as a tumor suppressor by inhibiting JAK2/STAT3 signaling pathways in head and neck squamous cell carcinoma.
Jin S; Yang X; Li J; Yang W; Ma H; Zhang Z
Mol Cancer; 2019 Mar; 18(1):38. PubMed ID: 30857539
[TBL] [Abstract][Full Text] [Related]
10. CD147 promotes progression of head and neck squamous cell carcinoma via NF-kappa B signaling.
Yu B; Zhang Y; Wu K; Wang L; Jiang Y; Chen W; Yan M
J Cell Mol Med; 2019 Feb; 23(2):954-966. PubMed ID: 30421493
[TBL] [Abstract][Full Text] [Related]
11. LASP1 promotes proliferation, metastasis, invasion in head and neck squamous cell carcinoma and through direct interaction with HSPA1A.
Chen Q; Wu K; Qin X; Yu Y; Wang X; Wei K
J Cell Mol Med; 2020 Jan; 24(2):1626-1639. PubMed ID: 31793711
[TBL] [Abstract][Full Text] [Related]
12. HPRT promotes proliferation and metastasis in head and neck squamous cell carcinoma through direct interaction with STAT3.
Wang L; Wang Y; Han N; Wang X; Ruan M
Exp Cell Res; 2021 Feb; 399(1):112424. PubMed ID: 33340493
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory mediators drive metastasis and drug resistance in head and neck squamous cell carcinoma.
St John MA
Laryngoscope; 2015 Mar; 125 Suppl 3():S1-11. PubMed ID: 25646683
[TBL] [Abstract][Full Text] [Related]
14. Carboxyl-Terminal Modulator Protein Positively Acts as an Oncogenic Driver in Head and Neck Squamous Cell Carcinoma via Regulating Akt phosphorylation.
Chang JW; Jung SN; Kim JH; Shim GA; Park HS; Liu L; Kim JM; Park J; Koo BS
Sci Rep; 2016 Jun; 6():28503. PubMed ID: 27328758
[TBL] [Abstract][Full Text] [Related]
15. KLF4, Slug and EMT in Head and Neck Squamous Cell Carcinoma.
Ingruber J; Savic D; Steinbichler TB; Sprung S; Fleischer F; Glueckert R; Schweigl G; Skvortsova II; Riechelmann H; Dudás J
Cells; 2021 Mar; 10(3):. PubMed ID: 33802627
[TBL] [Abstract][Full Text] [Related]
16. HOXB5 acts as an oncogenic driver in head and neck squamous cell carcinoma via EGFR/Akt/Wnt/β-catenin signaling axis.
Lee K; Chang JW; Oh C; Liu L; Jung SN; Won HR; Kim YI; Rha KS; Koo BS
Eur J Surg Oncol; 2020 Jun; 46(6):1066-1073. PubMed ID: 31864826
[TBL] [Abstract][Full Text] [Related]
17. Expression of Genes Encoding Cell Motility Proteins during Progression of Head and Neck Squamous Cell Carcinoma.
Kakurina GV; Kondakova IV; Spirina LV; Kolegova ES; Shashova EE; Cheremisina OV; Novikov VA; Choinzonov EL
Bull Exp Biol Med; 2018 Dec; 166(2):250-252. PubMed ID: 30488206
[TBL] [Abstract][Full Text] [Related]
18. RhoC regulates cancer stem cells in head and neck squamous cell carcinoma by overexpressing IL-6 and phosphorylation of STAT3.
Islam M; Sharma S; Teknos TN
PLoS One; 2014; 9(2):e88527. PubMed ID: 24533098
[TBL] [Abstract][Full Text] [Related]
19. STAT3/HOTAIR Signaling Axis Regulates HNSCC Growth in an EZH2-dependent Manner.
Sun S; Wu Y; Guo W; Yu F; Kong L; Ren Y; Wang Y; Yao X; Jing C; Zhang C; Liu M; Zhang Y; Zhao M; Li Z; Wu C; Qiao Y; Yang J; Wang X; Zhang L; Li M; Zhou X
Clin Cancer Res; 2018 Jun; 24(11):2665-2677. PubMed ID: 29540490
[No Abstract] [Full Text] [Related]
20. Phosphorylation of STAT3 in head and neck cancer requires p38 MAPKinase, whereas phosphorylation of STAT1 occurs via a different signaling pathway.
Riebe C; Pries R; Schroeder KN; Wollenberg B
Anticancer Res; 2011 Nov; 31(11):3819-25. PubMed ID: 22110204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
